Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

“The CRDMO space for mRNA became crowded during the pandemic, but much of that production process was built for capacity and not flexibility. We’re now seeing a clear shift toward personalized ...

VIDEO: S&P 500 Movers: MRNA, PLTR The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.